Dentis Achieves Record Quarterly Sales of 32.5 Billion KRW in Q1

Dentis, an implant-based dental and medical solutions company led by CEO Shim Kibong, recorded its highest-ever quarterly sales.

On May 15, Dentis announced its consolidated results for the first quarter of this year. Sales reached 32.481 billion KRW, up 14% year-on-year, while operating profit was 1.024 billion KRW, down 28% compared to the same period last year. A company representative explained, "Consistent sales growth continues across our three main business sectors: implants, operating room solutions, and clear aligners. Both the domestic and overseas markets are showing balanced growth." The representative added, "Although operating profit temporarily declined due to increased costs associated with the new factory operation and the overall expansion of business scale, we expect profitability to improve in the future, driven by the steep sales growth."

Dentis maintained solid growth in its core business sectors this quarter as well. The implant sector saw a 10% increase in sales year-on-year, the operating room solutions sector grew by 36%, and the clear aligner sector achieved 45% sales growth compared to the same period last year. As the company accelerates its global market expansion, its newly established Indian subsidiary, launched in September last year, has delivered rapid results for the second consecutive quarter, raising expectations. In addition, existing overseas subsidiaries, including those in China, are also showing clear growth, further strengthening the company's overall global competitiveness. Furthermore, the domestic market achieved 27% growth across all business sectors compared to the same period last year, maintaining a stable growth trajectory.

This year marks the 20th anniversary of Dentis, and the company has announced a new brand message and future vision to lead a new paradigm in the global healthcare industry based on its total dental and medical solutions. In June, the company plans to unveil a next-generation implant product, with a domestic launch scheduled for September. In addition, Dentis is completing the European CE MDR certification process for major dental equipment such as dental unit chairs, implant stability meters, and painless anesthesia devices, which is expected to drive overseas performance growth in the second half of the year.

In the operating room solutions sector, Dentis plans to build a more diversified lineup of surgical tables as soon as the overseas certification process for the ST300, its entry-level surgical table, is completed. Leveraging synergies with its existing surgical lighting products, the company aims to expand supply both domestically and internationally, which is expected to contribute to improved performance.

In the clear aligner sector, Dentis, through its subsidiary TNES, is enhancing its software and strengthening digital platform services. The company plans to accelerate its domestic market share expansion through a nationwide marketing campaign within this year.

A Dentis representative stated, "Thanks to balanced growth in both domestic and export sectors across our three business divisions, this year, marking our 20th anniversary, will be an important turning point." The representative added, "We also plan to accelerate our global market expansion by completing the establishment of new overseas subsidiaries in Thailand, Vietnam, Japan, and Poland this year."